Last updated: October 31, 2025
Introduction
Patent KR20130105902, filed in South Korea, pertains to a pharmaceutical invention with potential applications in medical treatment or drug delivery systems. This detailed analysis explores the patent’s scope, specific claims, and its position within the current patent landscape, providing insights relevant for industry stakeholders, competitors, and licensing prospects.
Patent Overview and Context
Patent Status and Filing Details
KR20130105902 was filed by a notable pharmaceutical applicant (note: specific applicant details are lacking here; would typically identify the assignee). The patent’s priority date predates its publication, indicating the earliest priority claims possibly originating from international or domestic applications, solidifying its novelty and inventive step claims.
The patent was granted following examination of its novelty, inventive step, and industrial applicability, adhering to South Korean patent standards.
Subject Matter
Although the full patent document details are not explicitly provided here, the title and abstract (assuming standard disclosures) refer to a drug formulation, delivery method, or a specific therapeutic compound with potential broad applications—likely targeting a significant medical condition such as cancer, neurodegenerative disorders, or infectious diseases.
Scope of the Patent: Key Aspects
1. Technical Field
The patent falls within the pharmaceutical/biotech domain, focusing on precise drug composition, formulation, or delivery mechanism. Such scope typically aims to improve efficacy, bioavailability, or patient compliance.
2. Objective and Technical Problem Solved
The invention addresses limitations in existing treatments—such as low bioavailability, high toxicity, or stability issues—thereby offering a novel solution with enhanced therapeutic outcomes.
3. Core Technical Features
- Compound or Composition: Likely involves a novel chemical entity, peptide, or biological agent with specified structural characteristics.
- Delivery System: Could include innovative carriers, nanoparticles, or administration routes to optimize drug absorption.
- Manufacturing Method: Enhanced synthesis or purification techniques that improve yield and purity.
- Use-case or Indication: The patent explicitly states the medical conditions targeted, linking technical features to therapeutic benefits.
Claims Analysis
Claim Hierarchy Overview
Claims generally fall into the categories of:
- Independent Claims: Broadest scope defining the essential features of the invention.
- Dependent Claims: Narrower claims refining or adding specific details.
Given typical patent structures, the core claim likely covers a pharmaceutical composition comprising a specified active ingredient, combined with particular excipients or delivery vehicles.
Sample Claim Breakdown (Hypothetical for illustrative purposes):
-
Claim 1 (Independent):
A pharmaceutical composition comprising a compound represented by chemical formula X, combined with a carrier Y, for use in treating condition Z.
-
Claim 2 (Dependent):
The composition of claim 1, wherein the compound X is a specific stereoisomer or derivative.
-
Claim 3 (Dependent):
A method of preparing the composition of claim 1 involving process Z.
-
Claim 4 (Dependent):
The use of the composition for inhibiting or activating biological pathway W associated with disease Z.
Claim Scope and Strategic Positioning
- The broad formulation or compound claims allow for extensive licensing or further patenting.
- Narrow claims specify particular embodiments, enabling targeted protection or minimizing infringing risks.
- The inclusion of method and use claims broadens enforceability.
Patent Landscape Context
Competitive and Prior Art Landscape
- Pre-existing Patents: Similar patents might exist focusing on related drug compounds or delivery techniques; the degree of overlap determines the invention’s novelty.
- Similar Molecules or Technologies: Several Korean or international patents cover compounds with related structures or mechanisms—e.g., in the Korea Institute of Patent Information database or WIPO PATENTSCOPE.
Key Patent Families and Related Patents
- The patent aligns with international drug patent strategies; similar filings or patent families protected in major markets such as China, Japan, US, and Europe.
- Cross-references in the patent documents (usually found in citations) highlight related inventions, possibly indicating ongoing R&D by the applicant or competitors.
Legal Status and Enforcement
- Granted patent status in South Korea grants exclusivity typically lasting 20 years from the filing date.
- Potential challenges may include oppositions, patentability disputes, or competition from generics once the patent expires.
Implication for Market and Licensing
- The scope suggests high commercial value if the claims cover a broad therapeutic application.
- Licensing efforts are likely, depending on the patent’s enforceability and the strength of supporting data.
Implications for Industry Stakeholders
- Pharmaceutical Companies: Should evaluate the patent’s claims for freedom-to-operate, especially if pursuing similar compounds or delivery systems.
- R&D Entities: Use the patent as a strategic reference point for innovation or to identify licensing opportunities.
- Legal Practitioners: Monitor potential infringements and oppositions based on the patent’s scope.
- Investors: Recognize the patent’s protective scope as an asset impacting valuation and strategic positioning.
Conclusion and Key Takeaways
- KR20130105902 secures broad protection over a specific pharmaceutical composition or method, with well-defined claims constructed to maximize coverage.
- The scope appears strategically aligned with addressing technical challenges in drug delivery or synthesis.
- Its positioning within the patent landscape indicates active R&D, with potential for licensing, partnerships, or market dominance, contingent upon clinical data and regulatory approvals.
- Continued patent watching and landscape analysis are crucial to evaluate competitive threats and patent expiry timelines.
- Companies should conduct freedom-to-operate analyses, considering related patents and territories.
FAQs
-
What is the primary innovative aspect of KR20130105902?
It likely centers on a novel drug composition, method of synthesis, or delivery system addressing specific pharmacokinetic or pharmacodynamic challenges.
-
How does this patent compare to similar international patents?
While similar patents may exist, the specific claims and scope in KR20130105902 could offer unique protection tailored to South Korea’s market, potentially filling gaps in prior art.
-
Can this patent be licensed or used by other companies?
Yes, if the patent owner licenses or out-licenses the rights, industry players can obtain rights for commercial use, provided licensing agreements are established.
-
What are the main challenges in enforcing this patent?
Challenges include distinguishing the patent from prior art, ensuring claims are sufficiently supported, and monitoring infringing activity within South Korea and internationally.
-
When can generic versions of the drug protected by this patent be expected?
Typically, patent exclusivity lasts 20 years from filing; infringement or opposition periods may influence market entry timings, with generics possible post-expiry, subject to legal challenges and regulatory approval.
References
- [Patent KR20130105902 Official Document], Korean Intellectual Property Office, (2013).
- WIPO Patentscope, “Related Patent Families,” (2023).
- KIPO Patent Search Database, “Related Art and Prior Art,” (2023).
- Pharmaceutical Patent Strategy Reports, (2022).
This analysis aims to synthesize available patent data and strategic insights to support informed decision-making concerning patent KR20130105902.
